z-logo
open-access-imgOpen Access
Magnetic Seizure Therapy for Suicidality in Treatment-Resistant Depression
Author(s) -
Cory R. Weissman,
Daniel M. Blumberger,
Julia Dimitrova,
Alanah Throop,
Daphne Voineskos,
Jonathan Downar,
Benoit H. Mulsant,
Tarek K. Rajji,
Paul B. Fitzgerald,
Zafiris J. Daskalakis
Publication year - 2020
Publication title -
jama network open
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.278
H-Index - 39
ISSN - 2574-3805
DOI - 10.1001/jamanetworkopen.2020.7434
Subject(s) - suicidal ideation , electroconvulsive therapy , psychiatry , depression (economics) , major depressive disorder , treatment resistant depression , bipolar disorder , medicine , psychological intervention , clinical psychology , poison control , suicide prevention , schizophrenia (object oriented programming) , emergency medicine , lithium (medication) , cognition , economics , macroeconomics
Key Points Question Is magnetic seizure therapy associated with decreased suicidality in patients with treatment-resistant depression? Findings This nonrandomized controlled trial of 67 patients in consecutive cohorts treated with magnetic seizure therapy found an overall remission rate from suicidality of 47.8%. Remission rates were higher in the low- and moderate-frequency treatment groups compared with the high-frequency group. Meaning These findings suggest that magnetic seizure therapy holds early promise as a treatment for suicidality in patients with treatment-resistant depression.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom